Staphylococcus aureus bacteremia: Difference between revisions
From IDWiki
Staphylococcus aureus bacteremia
m (→) |
No edit summary |
||
| Line 1: | Line 1: | ||
= Classification = |
== Classification == |
||
* '''Community-onset:''' positive blood culture obtained within 48 hours of presentation |
* '''Community-onset:''' positive blood culture obtained within 48 hours of presentation |
||
* '''Nosocomial:''' positive blood culture obtained after 48 hours of presentation |
* '''Nosocomial:''' positive blood culture obtained after 48 hours of presentation |
||
= Etiology = |
== Etiology == |
||
* IVDU |
* IVDU |
||
| Line 10: | Line 10: | ||
* Dental work |
* Dental work |
||
= Clinical Presentation = |
== Clinical Presentation == |
||
* Often non-specific fevers and chills, diagnosed on blood cultures |
* Often non-specific fevers and chills, diagnosed on blood cultures |
||
| Line 16: | Line 16: | ||
* May present with focus of metastatic disease |
* May present with focus of metastatic disease |
||
= Investigations = |
== Investigations == |
||
= Management = |
== Management == |
||
* Infectious diseases consultation |
* Infectious diseases consultation |
||
| Line 42: | Line 42: | ||
** Target trough 15-20 |
** Target trough 15-20 |
||
= Prognosis = |
== Prognosis == |
||
* Mortality 20-50% at 30 days, 60% at 1 year |
* Mortality 20-50% at 30 days, 60% at 1 year |
||
| Line 55: | Line 55: | ||
** Institutionalized patient |
** Institutionalized patient |
||
= Further Reading = |
== Further Reading == |
||
{{DISPLAYTITLE:''Staphylococcus aureus'' bacteremia}} |
{{DISPLAYTITLE:''Staphylococcus aureus'' bacteremia}} |
||
Revision as of 15:28, 17 August 2019
Classification
- Community-onset: positive blood culture obtained within 48 hours of presentation
- Nosocomial: positive blood culture obtained after 48 hours of presentation
Etiology
- IVDU
- Poor dentition
- Dental work
Clinical Presentation
- Often non-specific fevers and chills, diagnosed on blood cultures
- May have back pain unrelated to spinal osteomyelitis
- May present with focus of metastatic disease
Investigations
Management
- Infectious diseases consultation
- Must rule out endocarditis! TTE, followed by TEE if suspicion remains high
- Low risk for endocarditis (no TEE) if all of the following:
- No intracardiac device
- Sterile follow-up blood cultures within 4 days from the initial set
- No hemodialysis
- Nosocomial acquisition of S. aureus
- Absence of secondary foci
- No clinical signs of endocarditis
- Uncomplicated if
- Endocarditis is excluded
- No implanted prostheses
- Blood cultures clear by 2-4 days
- Defervesces within 72 hours
- No evidence of metastases
- +/- identified source has been removed
- Two-week course acceptable if uncomplicated, otherwise 4-6 weeks
- MSSA: cloxacillin 2g IV q4h for 2 weeks (cefazolin as an alternative)
- MRSA: vancomycin 1g IV q12h for 2 weeks
- Adjust based on serum trough before every fourth dose
- Target trough 15-20
Prognosis
- Mortality 20-50% at 30 days, 60% at 1 year
- Mortality halved by ID consult
- Prognosis worse with
- Increased age
- Female sex
- Pneumonia or source unknown
- Dementia
- Increasing comorbidities
- Shock at time of presentation
- Institutionalized patient
Further Reading
References
- ^ Anthony D. Bai, Carson KL. Lo, Adam S. Komorowski, Mallika Suresh, Kevin Guo, Akhil Garg, Pranav Tandon, Julien Senecal, Olivier Del Corpo, Isabella Stefanova, Clare Fogarty, Guillaume Butler-Laporte, Emily G. McDonald, Matthew P. Cheng, Andrew M. Morris, Mark Loeb, Todd C. Lee. Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis. Clinical Microbiology and Infection. 2022. doi:10.1016/j.cmi.2022.03.015.
- ^ Sarah Tubiana, Xavier Duval, François Alla, Christine Selton-Suty, Pierre Tattevin, François Delahaye, Lionel Piroth, Catherine Chirouze, Jean-Philippe Lavigne, Marie-Line Erpelding, Bruno Hoen, François Vandenesch, Bernard Iung, Vincent Le Moing. The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. Journal of Infection. 2016;72(5):544-553. doi:10.1016/j.jinf.2016.02.003.
- ^ Thomas W van der Vaart, Jan M Prins, Robin Soetekouw, Gitte van Twillert, Jan Veenstra, Bjorn L Herpers, Wouter Rozemeijer, Rogier R Jansen, Marc J M Bonten, Jan T M van der Meer. Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 2021;74(8):1442-1449. doi:10.1093/cid/ciab632.
